Inactive Instrument

News Horizon Pharma Inc Nasdaq

Equities

US44047T1097

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jan. 16	Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders	CI
2023	Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla...

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders	Jan. 16	CI
Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla...	23-10-09
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC	23-10-09	AQ
Horizon Therapeutics Public Limited Company Announces the Cessation of Member of the Board of Directors	23-10-06	CI
Rule 17(d) Announcement, Horizon Therapeutics plc	23-10-06	AQ
Amgen completes $27.8 bln Horizon deal	23-10-06	RE
Amgen Completes Acquisition of Horizon Therapeutics	23-10-06	MT
Amgen completes acquisition of Horizon Therapeutics	23-10-06	RE
Rule 17(e) Announcement - Horizon Therapeutics plc	23-10-06	BU
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from NASDAQ Composite Index	23-10-06	CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from FTSE All-World Index	23-10-06	CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from S&P Global BMI Index	23-10-06	CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from S&P TMI Index	23-10-06	CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from S&P Biotechnology Select Industry Index	23-10-06	CI
Horizon Therapeutics Public Limited Company's Equity Buyback announced on September 9, 2022, has expired.	23-10-05	CI
Amgen Inc. completed the acquisition of Horizon Therapeutics Public Limited Company.	23-10-05	CI
Amgen Wins Irish Court Approval to Acquire Horizon Therapeutics	23-10-05	MT
Rule 17(d) Announcement – Horizon Therapeutics plc	23-10-05	BU
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from NASDAQ Biotechnology Index	23-10-05	CI
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)	23-10-03	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Horizon Pharma Inc Nasdaq

Equities

US44047T1097

Summary

Filters